Transforming IP portfolios into a business growth engine

COZAREN empowers biopharma and agrochemical innovators to unlock the full potential of their IP. Using AI-driven chemical and biosequence searches, competitive intelligence and strategic advisory, we transform patents into strategic business assets to maximise value, mitigate risk and accelerate market success.

Patent & Biosequence Intelligence

Maximise value

Reduce risk

Move faster

About COZAREN See capabilities

28+ yrs

biopharma & agrochemical IP

Novartis · IMS Health

senior leadership roles

Teva · Clarivate

science, IP & strategy

Capabilities overview

Four disciplines, one commercial goal

Every engagement is built to make one thing clearer: what your IP is worth, where the risk sits, and how to move on it.

AI-Integrated Biosequence Search Platforms

Harness AI with gold-standard algorithms like BLAST and Smith-Waterman. Our scalable bioinformatics platforms help IP, R&D and regulatory teams work faster and with greater precision.

High-precision protein & nucleotide sequence searches
Motif-based searches with up to five mismatches
Motif-based searches with up to five mismatches
Hybrid searches combining sequence data & keyword filters

Visit genepat.com

SEQ · BLAST

Patent & Competitive Intelligence Searches

Make decisions with confidence. Our patent and market intelligence services deliver critical insights for IP strategy, M&A, licensing and investment due diligence.

Novelty & patentability searches
Validity & opposition searches
Freedom-to-operate (FTO) analyses; and,
IP landscape & trend mapping to benchmark competitors and identify whitespace opportunities.

SRCH · A61P

Due Diligence Support for IP Transactions

High-stakes deals demand precise, risk-informed insights. Partnering with experienced patent attorneys, we provide end-to-end IP due diligence across the lifecycle.

We support:

Licensing & acquisition evaluations.
Investment & partnership negotiations.
R&D collaborations & joint ventures.
Commercialisation readiness assessments

DILG · C07K

Patent Portfolio Optimisation & Licensing

Your patents should drive growth, not sit idle. We align IP strategy with commercial objectives to maximise revenue, reduce risk and unlock long-term value.

Licensing or litigation support to enforce patent rights
Early infringement & litigation risk assessments
Investor connections to accelerate biopharma development
Monetisation of non-core IP via licensing, transfer or divestiture

PORT · C12N

Investment Facilitation for Ophthalmic, BCI & Biotech Development

Beyond maximising the value of an IP portfolio, COZAREN helps advance drug and device development through strategic investment facilitation — connecting breakthrough science with capital ready to move.

We work closely with China-based investors actively seeking opportunities in ophthalmic, brain-computer interface and biotechnology projects. If your organisation is developing breakthrough technology and seeking investment to accelerate progress, get in touch.

Ophthalmic technologies
Brain-computer interfaces (BCI)
Biotechnology

INVEST · A61F

About the founder

28 years at the intersection of science, IP and strategy

Cornelius Enuezie brings over 28 years of experience in biopharmaceutical and agrochemical patents, combined with senior leadership roles across industry-leading organisations, including Novartis, IMS Health, Teva and Clarivate.

That career built a deep expertise at the intersection of science, intellectual property and commercial strategy, technical fluency in chemical and biosequence patents, paired with the commercial instinct to turn a portfolio into revenue.

Cornelius combines

Advanced technical knowledge in chemical & biosequence patents

Strong commercial & strategic insight

Specialist expertise in patent search & competitive intelligence

Which enables him to

Build high-performing licensing & IP monetisation programmes

Identify untapped revenue opportunities within portfolios

Strengthen the revenue-generating capabilities of biopharma organisations